Grant proceeds support an ongoing early feasibility study of Orion LOS ANGELES–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable visual prostheses that are intended to create an artificial form of useful vision for blind individuals, today announced that the Company received notice from the National … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Global Ambulatory IV infusion Pumps Market Report 2022” report has been added to ResearchAndMarkets.com’s offering. The global ambulatory iv infusion pumps market is expected to grow from $0.75 billion in 2021 to $0.78 billion in 2022 at a compound annual growth rate (CAGR) of 4.5%. The market is expected to grow to $0.89 … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Global Hematology Diagnostic Devices And Equipment Market Report 2022” report has been added to ResearchAndMarkets.com’s offering. The global hematology diagnostic devices and equipment market is expected to grow from $1.64 billion in 2021 to $1.91 billion in 2022 at a compound annual growth rate (CAGR) of 16.4%. The market is expected to grow … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “The Pharma Mini MBA Training Course” conference has been added to ResearchAndMarkets.com’s offering. Working in the highly competitive pharmaceutical industry, with ever-increasing change and pressure, is probably one of the most challenging managerial roles of any industry today. This event has been especially designed to help you transcend these challenges by training you … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “EU (European Union) Artificial Intelligence (AI) Act and its Impact on Medical Device Manufacturers Training Course” conference has been added to ResearchAndMarkets.com’s offering. Many companies take part in the global ‘race to AI’ by continuously broadening the role of AI in their product portfolio. However, the rules of the game appear to be … [Read more…]
LUXEMBOURG & GREENWICH, Conn. & LONDON–(BUSINESS WIRE)–Astorg and Amulet Capital Partners (“Amulet”) today announced that they have completed the previously announced transaction whereby Astorg has acquired OPEN Health, a leading global provider of scientific communications and market access services to the pharmaceutical industry. Established in 2011 and with more than 1,000 employees in 15 locations … [Read more…]
Antonio Costanzo to Remain with the Company to Focus on M&A and Regulatory Affairs New CPG-focused President to drive next phase of growth as the European cannabis market opens up LONDON–(BUSINESS WIRE)–Curaleaf International (the “Company” or “Group”), Europe’s largest vertically integrated cannabis company, is pleased to announce that it has appointed Miles Worne as President, … [Read more…]
PARSIPPANY, N.J.–(BUSINESS WIRE)–IVERIC bio, Inc. (Nasdaq: ISEE) announced today that in a post-hoc analysis from the GATHER1 clinical trial, Zimura showed a reduction of geographic atrophy lesion growth, compared to sham, across all distances from the foveal center point. The analysis was presented by David R. Lally, MD, Director of Retina Research Institute at New … [Read more…]
WALTHAM, Mass.–(BUSINESS WIRE)–Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today announced that in connection with the hiring of Kelley Dealhoy, Senior Vice President and Chief Business Officer, the Compensation Committee of Deciphera’s Board of Directors approved the … [Read more…]
CHICAGO–(BUSINESS WIRE)–Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or the “Company”), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, conducted its annual and special meeting of shareholders (the “Meeting”) today, July 15, 2022 at 10:00 a.m. (Central Time). At the Meeting, the number of directors on the board of … [Read more…]
